AGIOS PHARMACEUTICALS, INC. Costs and Expenses in USD from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to Q3 2025.
  • Agios Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2025 was $130M, a 16.1% increase year-over-year.
  • Agios Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2025 was $520M, a 18.3% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2024 was $462M, a 10.5% increase from 2023.
  • Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $418M, a 3.73% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $403M, a 6.57% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $520M $130M +$18M +16.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 $502M $140M +$25.1M +21.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $477M $115M +$15.1M +15.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $462M $136M +$22.4M +19.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 $440M $112M +$3.48M +3.21% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 $436M $114M +$14M +14% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $422M $100M +$4.04M +4.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 $418M $113M +$9.9M +9.57% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 $408M $108M +$13.7M +14.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $395M $100M -$2.81M -2.72% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $398M $96.2M -$5.76M -5.64% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $403M $103M -$1.35M -1.28% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 $405M $94.6M +$3.45M +3.79% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $401M $103M +$12M +13.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $389M $102M +$10.8M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $378M $105M +$19.5M +22.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $359M $91.2M +$10.9M +13.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $348M $91.2M +$7.96M +9.56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $340M $91.2M +$4.19M +4.81% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $336M $85.3M +$172M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $164M $80.3M -$54.8M -40.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $219M $83.3M -$56.8M -40.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $276M $87M -$40.7M -31.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $316M -$86.6M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $135M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $140M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $128M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30

AGIOS PHARMACEUTICALS, INC. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $462M +$43.9M +10.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $418M +$15M +3.73% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $403M +$24.9M +6.57% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 $378M +$42.5M +12.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $336M +$19.6M +6.21% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $316M -$141M -30.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $457M +$93.1M +25.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $364M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.